Division of Genetic Medicine and Clinical Pharmacology Archive — Page 9 of 12

March 17, 2022

U.S. precision medicine research program releases genomic data

The All of Us Research Program released an initial large batch of genomic data on its cloud-based research platform, the Researcher Workbench, including whole genome sequences of 98,600 research participants and genotype data from 165,200 participants.

February 24, 2022

VUMC researchers find clue to drug-induced arrhythmias

Vanderbilt University Medical Center researchers have made a fundamental discovery about how the heart compensates for genetic variations that otherwise could trigger abnormal and potentially fatal heart rhythms.

Vanderbilt Center for Tourette Syndrome and Other Tic Disorders team members include, from left, Angela White, RN, Mariana Ciobanu, MD, KellyAnn Primm, OTR/L, David Isaacs, MD, MPH, Heather Riordan, MD, Michelle Eckland, Jessica Stroh, RN, and Kayla Johnson, PharmD.
February 23, 2022

VUMC designated a Tourette syndrome center of excellence

The Vanderbilt Center for Tourette Syndrome and Other Tic Disorders has been designated a Tourette Association of America (TAA) Center of Excellence.

December 2, 2021

Gene discoveries give new hope to people who stutter

New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter.

December 2, 2021

Study links depression scores, white blood cell count

(iStock)
November 30, 2021

Study examines genetic risk for suicide attempt

New research from Vanderbilt identifies the first replicated genomic region contributing to risk of suicide attempt and confirms that genetic risk for the trait is not driven solely by risk for psychiatric disorders.